Clinical Trial Update: Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists [NA]

View source ↗

Summary

A pragmatic trial evaluating alerts for the use of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Spironolactone (spironolactone)
• eplerenone (eplerenone)

Snippet

Sponsor: Yale University | Conditions: Heart Failure With Reduced Ejection Fraction | NA | Status: COMPLETED